ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kakaiya, R.
Right arrow Articles by Morse, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kakaiya, R.
Right arrow Articles by Morse, E.
Annals of Clinical and Laboratory Science, Vol 14, Issue 4, 276-284
Copyright © 1984 by Association of Clinical Scientists


Articles

Characteristics and natural history of alloimmunization following HLA-matched leukocyte transfusion in Hunter's syndrome

RK Kakaiya, R Greenstein, PT Pisciotto, SK Slocum, D Rosen, RG Cable, and EE Morse

The characteristics and natural history of alloimmunization to HLA were studied in five patients with Hunter's syndrome receiving long term transfusions of leukocytes collected from human leukocyte antigen (HLA) matched donors. Patients were not given any other blood component transfusions. All patients became alloimmunized at an average interval of eight months following an average of 15 transfusions. All patients developed HLA alloantibodies to transfused cross-reactive HLA antigens. Antibodies to transfused incompatible HLA antigens also developed in all patients. Multispecific HLA antibodies in which specificity determination could not be made were also seen in four patients. In a small number of patients in this study, despite matching for the private HLA specificities, HLA alloimmunization was not prevented. In fact, broad alloimmunization was seen uniformly in our patients.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the Association of Clinical Scientists.